New Key Statistics Module, Z-Score and F-Score
OSTO:IMMNOV Key Ratios
| Market Cap kr M | 135.43 |
| Enterprise Value kr M | 107.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 0.13 |
| Price/Book | 3.87 |
| Price/Sales | 76.10 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | -- |
| EPS (TTM) kr | -1.31 |
| Beneish M-Score | -4.64 |
| 10-y EBITDA Growth Rate % | -42.50 |
| 5-y EBITDA Growth Rate % | -0.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.92 |
| EV-to-EBITDA | -1.00 |
| PEG | -- |
| Shares Outstanding M | 169.29 |
| Net Margin (%) | -13,120.79 |
| Operating Margin % | -12,487.46 |
| Pre-tax Margin (%) | -13,120.79 |
| Quick Ratio | 1.10 |
| Current Ratio | 1.10 |
| ROA % (ttm) | -102.28 |
| ROE % (ttm) | -163.60 |
| ROIC % (ttm) | -194.22 |
| Dividend Yield % | -- |
| Altman Z-Score | -30.49 |
OSTO:IMMNOV Number of Guru Trades
OSTO:IMMNOV Volume of Guru Trades
Gurus Latest Trades with OSTO:IMMNOV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OSTO:IMMNOV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers